NCT04939480View on ClinicalTrials.gov

Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 6, 2021

Primary Completion Date

March 14, 2024

Study Completion Date

March 14, 2024

Conditions
Squamous Cell Carcinoma of Head and Neck
Interventions
DRUG

Atezolizumab

Atezolizumab 1200 mg intravenous solution

Trial Locations (1)

45147

University Hospital Essen, Essen

All Listed Sponsors
lead

University Hospital, Essen

OTHER

NCT04939480 - Window of Opportunity Study of Preoperative Immunotherapy With Atezolizumab in Local SCCHN | Biotech Hunter | Biotech Hunter